?Adding content: Expanding biomarker portfolio in Personalized Healthcare; products from Cellestis and Ipsogen acquisitions contribute to growth in second half of 2011
http://www.prnewswire.com/news-releases/qiagen-reports-fourth-quarter-and-full-year-2011-results-138428014.html
- Forums
- ASX - By Stock
- CST
- can you hear that?
can you hear that?, page-10
-
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CST (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.90M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 13842 | 7.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.3¢ | 36144 | 1 |
Last trade - 10.26am 25/11/2024 (20 minute delay) ? |
Featured News
CST (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online